"
COVID-19 Research Working Group

Leading Coronavirus Research

News

Genome Variation Gives Insight Into Coronavirus Spread

April 02, 2020

As SARS-CoV-2 has spread around the world, its transmission rate has varied alongside variations in its genome, according to researchers at the University of California, Davis. Surveillance of the virus genome may help public authorities target areas about to experience an upsurge of infection. 

PREDICT Receives Extension for COVID-19 Pandemic Emergency Response

March 31, 2020

PREDICT will provide emergency support to other countries for outbreak response including technical support for early detection of SARS CoV-2, the virus that causes the disease COVID-19, through a six-month extension from the U.S. Agency for International Development, or USAID, effective April 1.

What the blood tests of a COVID-19 patient can tell us

March 31, 2020

A blood test result more typically seen in disorders associated with bone marrow diseases was found in a patient with COVID-19, a viral infection caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The findings were published March 25 in the American Journal of Hematology

Solving a medical mystery and changing CDC screenings for COVID-19

March 30, 2020
What we learned from the first known community-acquired coronavirus case in the U.S. (SACRAMENTO) — When UC Davis announced the first case of community transmission of COVID-19 in the U.S. on Feb. 26, it solved a medical mystery at the hospital and led to important changes to the U.S.

Virtual Town Halls Held Every Friday for Campus Researchers

March 30, 2020

COVID-19 Research Virtual Town Halls will be held from 10:30 to 11:30 a.m. every Friday starting April 3, The forum for campus researchers will be moderated by Allison Brashear, dean of the School of Medicine, and Prasant Mohapatra, vice chancellor of research.

Like the Research Accelerator Fund, the town halls are open to UC Davis researchers from all disciplines working on COVID-19-related research.

UC Davis launches two clinical studies to treat COVID-19

March 26, 2020

UC Davis Health has two clinical trials underway for hospitalized patients with severe COVID-19, the disease caused by the novel coronavirus, SARS-CoV-2. The studies are evaluating the safety and effectiveness of two drugs — the investigational antiviral remdesivir, and sarilumab, a drug that blocks the body’s acute inflammatory response.

Read more.